Anna V. Senina
Anna V. Senina publishes mostly in Hematology, Genetics and Molecular Biology, on topics such as Chronic Myeloid Leukemia Treatments, Chronic Lymphocytic Leukemia Research and Myeloproliferative Neoplasms: Diagnosis and Treatment.
- World rank
- #2,155,391 of 7,710,434 ranked researchers
- Rank in United States
- #648,408 of 1,627,098
- Works
- 87
- Citations
- 858
- Citations per work
- 9.9
What does Anna V. Senina research?
Anna V. Senina's work is mostly in Medicine (53%), Biochemistry, Genetics and Molecular Biology (21%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences4652.7%
- Medicine4652.7%
- Everything else2326.7%
- Life Sciences1820.6%
- 1Hematology22% of their works
- 2Genetics17% of their works
- 3Molecular Biology16% of their works
- 4Oncology10% of their works
- 5Cancer Research4% of their works
- 6Geriatrics and Gerontology4% of their works
Research topics
Which keywords describe Anna V. Senina's research?
The keywords of their largest research topics: Mutation, Prognostic Factors, BCR-ABL, Imatinib, Chronic Lymphocytic Leukemia, Genomic Aberrations, JAK2 Mutation and Myelofibrosis.
- Warburg Effect
- Resveratrol
- HIF-1
- Cell Cycle
- AML
- Myelofibrosis
- Genomic Aberrations
- Imatinib
- Prognostic Factors
- Mutation
- BCR-ABL
- Chronic Lymphocytic Leukemia
- JAK2 Mutation
- Cancer Therapy
- Acute Myeloid Leukemia
- HDAC Inhibitors
- Histone Deacetylases
- Sirtuins
- p53
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 19 words, with their numbers
- Mutation202 topics
- Prognostic Factors172 topics
- BCR-ABL161 topic
- Imatinib161 topic
- Chronic Lymphocytic Leukemia101 topic
- Genomic Aberrations101 topic
- JAK2 Mutation91 topic
- Myelofibrosis91 topic
- Cancer Therapy82 topics
- AML71 topic
- Acute Myeloid Leukemia71 topic
- Cell Cycle41 topic
- HDAC Inhibitors41 topic
- HIF-141 topic
- Histone Deacetylases41 topic
- Resveratrol41 topic
- Sirtuins41 topic
- Warburg Effect41 topic
- p5341 topic
Where does Anna V. Senina work?
Anna V. Senina's main affiliation in the publication record is Huntsman Cancer Institute, United States.
How many publications and citations does Anna V. Senina have?
OpenAlex counts 87 works and 858 citations for Anna V. Senina, an h-index of 11, ranking #2,155,391 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Anna V. Senina. Posts are plain text and can be reported.